title: Reducing the burden of coronary artery disease in India: challenges and opportunities.
abstract: Asian Indians--living both in India and abroad--have one of the highest rates of coronary artery disease (CAD) in the world, three times higher than the rates among Caucasians in the United States. The CAD among Indians is usually more aggressive at the time of presentation compared with whites or East Asians. The overall impact is much greater because the CAD in Asian Indians affects the "younger" working population. This kind of disproportionate epidemic among the young Indians is causing tremendous number of work days lost at a time when India is experiencing a dizzying economic boom and needs a healthy populace to sustain this boom. While the mortality and morbidity from CAD has been falling in the western world, it has been climbing to epidemic proportions among the Indian population. Various factors that are thought to contribute to this rising epidemic include urbanization of rural areas, large-scale migration of rural population to urban areas, increase in sedentary lifestyle, abdominal obesity, metabolic syndrome, diabetes, inadequate consumption of fruits and vegetables, increased use of fried, processed and fast foods, tobacco abuse, poor awareness and control of CAD risk factors, unique dyslipidemia (high triglycerides, low HDL-cholesterol levels), and possible genetic predisposition due to lipoprotein (a) [Lp(a)] excess. The effect of established, as well as novel, risk factors is multiplicative, not just additive (total effect>sum of parts). The management would require aggressive individual, societal, and governmental (policy and regulatory) interventions. Indians will require specific lower cut-offs and stricter goals for treatment of various risk factors than is currently recommended for western populations. To this end, the First Indo-US Healthcare Summit was held in New Delhi, India on December 14 and 15, 2007. The participants included representatives from several professional entities including the American Association of Physicians of Indian origin (AAPI), Indian Medical Association (IMA), Medical Council of India (MCI), and Government of India (GOI) with their main objective to address specific issues and provide precise recommendations to implement the prevention of CAD among Indians. The summary of the deliberations by the committee on "CAD among Asian Indians" and the recommendations are presented in this document.
  
  
  OBJECTIVE
  Discussion of demographics of CAD in Indians-both in India and abroad, current treatment strategies, primordial, primary, and secondary prevention. Development of specific recommendations for screening, evaluation and management for the prevention of CAD disease epidemic among Asian Indians. Recommendations for improving quality of care through professional, public and private initiatives.
authors.affiliation: Coronary Artery Disease in Asian Indians (CADI) Research Foundation, Lisle, IL 60532, USA. enas@cadiresearch.com
authors.forename: Enas A
authors.initials: EA
authors.lastname: Enas
authors.forename: Vibhuti
authors.initials: V
authors.lastname: Singh
authors.forename: Y P
authors.initials: YP
authors.lastname: Munjal
authors.forename: Suman
authors.initials: S
authors.lastname: Bhandari
authors.forename: Ram Dev
authors.initials: RD
authors.lastname: Yadave
authors.forename: S C
authors.initials: SC
authors.lastname: Manchanda
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents; D003324:Coronary Artery Disease / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control* / Q000601:surgery; D006801:Humans; D007194:India / Q000453:epidemiology; D008019:Life Style; D008403:Mass Screening; D009043:Motor Activity; D017410:Practice Guidelines as Topic / Q000592:standards; D011322:Primary Prevention / Q000379:methods*; D012307:Risk Factors
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents